General Information of This Metabolic Reaction (MR) (ID: MR003759)
Formula Reactant LY-450139 Product LY-2484595 Metabolite M2
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003762 LY-450139 LY-2484595 Metabolite M3 Oxidation - Benzylic hydroxylation LY-450139 [1]
MR003761 LY-450139 LY-2484595 Metabolite M4 Unclear LY-450139 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003747 LY-2484595 LY-2484595 Metabolite M2 Oxidation - Oxidationn LY-2484595 [2]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003748 LY-2484595 Metabolite M2 LY-2484595 Metabolite M1 Unclear LY-2484595 [2]
MR003751 LY-2484595 Metabolite M2 LY-2484595 Metabolite M20 Oxidation - Oxidationn LY-2484595 [2]
MR003760 LY-2484595 Metabolite M2 LY-2484595 Metabolite M30 Conjugation - Glucuronidation LY-450139 [1]
MR003750 LY-2484595 Metabolite M2 LY-2484595 Metabolite M6 Unclear LY-2484595 [2]
References
1 Disposition and metabolism of semagacestat, a {gamma}-secretase inhibitor, in humans. Drug Metab Dispos. 2010 Apr;38(4):554-65.
2 Evacetrapib: in?vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.